Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children.
Autorzy:
Liu Z; Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Hunter Medical Research Institute, Kookaburra Circuit, Australia.; Clinical Pharmacology, Department of Medicine, The Royal Children's Hospital Melbourne, Australia.; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia. Julsgaard M; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Gastroenterology, St Vincent's Hospital, and University of Melbourne, Melbourne, Australia. Zhu X; Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fudan University, China.; School of Pharmacy, University of Otago, Dunedin, New Zealand. Martin J; Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Hunter Medical Research Institute, Kookaburra Circuit, Australia. BarclayML; Departments of Gastroenterology & Clinical Pharmacology, Christchurch Hospital, Christchurch, New Zealand. Cranswick N; Clinical Pharmacology, Department of Medicine, The Royal Children's Hospital Melbourne, Australia. Gibson PR; Department of Gastroenterology, Alfred Hospital, and Monash University, Melbourne, VIC, Australia. Gearry RB; Department of Medicine, University of Otago, Christchurch, New Zealand. van der Giessen J; Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands. Connor SJ; Department of Gastroenterology, Liverpool Hospital, Sydney.; South Western Sydney Clinical, University of NSW Sydney.; Ingham Institute of Applied Medical Research, Sydney, Australia. Rosella O; Department of Gastroenterology, Alfred Hospital, and Monash University, Melbourne, VIC, Australia. Grosen A; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark. Toong C; South Western Sydney Clinical, University of NSW Sydney.; Sydney South West Pathology Service, Liverpool Hospital, University of NSW, Sydney, Australia. Flanagan E; Department of Gastroenterology, St Vincent's Hospital, and University of Melbourne, Melbourne, Australia. Wieringa JW; Department of Pediatrics, Haaglanden Medical Center, the Hague, The Netherlands.; Department of Pediatrics, Division of Paediatric Infectious Diseases and Immunology, Erasmus MC University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands. Janneke van der Woude C; Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands. Bell SJ; Department of Gastroenterology, St Vincent's Hospital, and University of Melbourne, Melbourne, Australia.; Department of Gastroenterology, Monash Health, and School of Clinical Sciences Monash University, Melbourne, VIC, Australia.
Systematic review with meta-analysis: SARS-CoV-2 stool testing and the potential for faecal-oral transmission.
Autorzy:
van Doorn AS; Departments of Gastroenterology & Clinical Pharmacology, Christchurch Hospital, Canterbury District Health Board and University of Otago, Christchurch, New Zealand.; Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. Meijer B; Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; Department of Gastroenterology and Hepatology, Noordwest Ziekenhuisgroep Alkmaar, the Netherlands. Frampton CMA; Department of Biostatistics & Medicine, Christchurch Hospital, Canterbury District Health Board and University of Otago, Christchurch, New Zealand. BarclayML; Departments of Gastroenterology & Clinical Pharmacology, Christchurch Hospital, Canterbury District Health Board and University of Otago, Christchurch, New Zealand. de Boer NKH; Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives.
Autorzy:
de Boer NKH; Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands. Peyrin-Biroulet L; Department of Gastroenterology and Hepatology and Inserm U954, Nancy University Hospital, Lorraine University, Vandoeuvre-lès-Nancy, France. Jharap B; Department of Gastroenterology, Meander Medical Centre, Amersfoort, The Netherlands. Sanderson JD; Department of Gastroenterology, Guy's and St Thomas' Hospitals, London, UK. Meijer B; Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands. Atreya I; Department of Gastroenterology, Pneumology and Endocrinology, Universitätsklinikum Erlangen, University of Erlangen-Nürnberg, Germany. BarclayML; Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand. Colombel JF; Department of Gastroenterology, Mount Sinai Hospital, New York, NY, USA. Lopez A; Department of Gastroenterology and Hepatology and Inserm U954, Nancy University Hospital, Lorraine University, Vandoeuvre-lès-Nancy, France. Beaugerie L; Department of Gastroenterology, AP-HP, Hôpital Saint-Antoine,UPMC University, Paris, France. Marinaki AM; Purine Research Laboratory, Guy's and St Thomas' Hospitals, London, UK. van Bodegraven AA; Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands.; Department of Gastroenterology, Geriatrics, Internal and Intensive Care Medicine [Co-MIK], Zuyderland Medical Centre, Heerlen-Sittard-Geleen, The Netherlands. Neurath MF; Department of Gastroenterology, Pneumology and Endocrinology, Universitätsklinikum Erlangen, University of Erlangen-Nürnberg, Germany.
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).
Autorzy:
Friedman AB; Department of Gastroenterology, The Alfred Hospital and Monash University, Melbourne, Australia. Brown SJ; St Vincent's Hospital, Melbourne, Australia. Bampton P; Flinders medical Centre, Adelaide, Australia. BarclayML; Christchurch Hospital, Christchurch, New Zealand. Chung A; Eastern Health and Monash University, Melbourne, Australia. Macrae FA; Royal Melbourne Hospital, Melbourne, Australia. McKenzie J; The Alfred Hospital and Monash University, Melbourne, Australia. Reynolds J; The Alfred Hospital and Monash University, Melbourne, Australia. Gibson PR; The Alfred Hospital and Monash University, Melbourne, Australia. Hanauer SB; Northwestern University, Chicago, USA. Sparrow MP; The Alfred Hospital and Monash University, Melbourne, Australia.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies